Dopamine replacement medication improves acquisition, retention, and transfer of skilled upper extremity movement in people with Parkinson Disease.
Objective: To determine whether i) dopamine replacement medication affects learning of an upper limb (UL) feeding task in people with Parkinson disease (PD), and ii) training…Evaluation of the short-term and long-term effects of an intensive multidisciplinary collective rehabilitation program over 5 weeks in Parkinson’s patients followed in Lyon
Objective: We studied the value of collective (8 patients per group) intensive multidisciplinary collective rehabilitation in the short and long term. Background: Numerous studies have proved…Antisense oligonucleotides containing amido-bridged nucleic acid downregulate SNCA expression and improve motor function in Parkinson’s disease mouse models.
Objective: In this study, we used gapmer-type antisense oligonucleotides (ASOs) containing amido-bridged nucleic acid (AmNA). ASO, short single-stranded stretches of DNA or RNA with complementary…Parkinson’s Disease Medications Availability in Each Philippine Region
Objective: This study aimed to enumerate the different Parkinson’s disease medications in the Philippines and describe the distribution and availability among the 17 regions of…CB2R agonist AM1241 reverses the development of MPTP-induced PD and activates the regeneration of DA neurons
Objective: A promising and potential direction to treat PD is to develop new non-dopaminergic drugs without producing dyskinesia, as well as arresting and even reversing…Pairing TMS and physical therapy for treatment of gait and balance disorders in Parkinson’s Disease: a randomized pilot trial
Objective: To explore the feasibility of pairing repetitive transcranial magnetic stimulation (rTMS) back-to-back with standard of care physical therapy (PT) for posture instability and gait…Determinant factors of treatment adherence in Parkinson’s disease
Objective: To determine factors predicting treatment adherence in patients with idiopathic Parkinson’s disease. Background: Parkinson’s disease is the second most common cause of neurodegenerative disease…Closed Loop STN DBS for Tremor in Parkinson’s disease using a Neural or Kinematic Signal
Objective: Compare safety, tolerability, efficiency and efficacy of closed loop DBS (clDBS) of the subthalamic nucleus (STN) for resting tremor in Parkinson’s disease (PD) using…Comparison of neurotoxic potency of a newly produced Botulinum Neurotoxin Type A with onabotulinumtoxinA, incobotulinumtoxinA and BotulinumtoxinA
Objective: This study aims to compare the neurotoxic potency of four different kinds of toxins, accompanied with expression level changes of key factors after BoNT/A…The therapeutic effects of cortical electrical stimulation in an animal model of Parkinson’s disease
Objective: In this study, we first designed the long-term implantable cortical electrical stimulation (CES) module in a rat model of Parkinson's disease (PD). With the…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.